Fullerton Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Fullerton Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$611K	Buy	+10,069	New	+$587K	0.05%	55
2025 Q3	–	Sell	-3,547	Closed	-$164K	–	100
2025 Q2	$164K	Sell	3,547 -4,750	-57%	-$233K	0.01%	93
2025 Q1	$506K	Buy	+8,297	New	+$484K	0.03%	82
2024 Q2	–	Sell	-9,408	Closed	-$510K	–	139
2024 Q1	$510K	Buy	+9,408	New	+$479K	0.02%	71
2021 Q3	–	Sell	-3,538	Closed	-$236K	–	69
2021 Q2	$236K	Buy	+3,538	New	+$231K	0.02%	76
2020 Q4	–	Sell	-3,180	Closed	-$192K	–	81
2020 Q3	$192K	Buy	+3,180	New	+$191K	0.03%	58

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fullerton Fund Management's BMY Position: Q1 2026 in Review

Fullerton Fund Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 10,069 shares worth $611K. The stake represents 0.05% of the portfolio and ranks #55 among its holdings. This is a return to the name: Fullerton Fund Management previously reported a position in BMY as recently as Q2 2025.

Fullerton Fund Management first reported a position in BMY in Q3 2020 and has held it in 6 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Fullerton Fund Management held 10,069 shares of Bristol-Myers Squibb worth $611K as of Q1 2026.
Bristol-Myers Squibb was a new Fullerton Fund Management position in Q1 2026.
Bristol-Myers Squibb made up 0.05% of Fullerton Fund Management's portfolio in Q1 2026, its #55 holding.
Fullerton Fund Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 6 quarters since.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fullerton Fund Management's 13F filing for Q1 2026, filed 15 May 2026.